-
Not doing everything we can to help mitigate the increasing prevalence of diabetes bodes ill for world health and health care systems
Medical Mythbusting Commentary for November 15, 2024 Source:Diabetes in adults nearly doubles worldwide, study suggests Reference:Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants
-
Vision and hearing loss among growing list of risk factors for dementia, study says
Medical Mythbusting Commentary for August 7, 2024 Source:Time to get your eyes checked: Vision loss among growing list of risk factors for dementia, study says Reference:Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission
-
Popular weight loss and diabetes drugs linked to increased risk of rare form of blindness. Study authors state that causality is not established. The health benefits of controlling diabetes, reduced heart, liver, kidney, and brain disease need to be considered with its use.
Medical Mythbusting Commentary for July 4, 2024 Source:Popular weight loss and diabetes drugs linked to increased risk of rare form of blindness
-
World’s first weekly insulin injection coming to Canada in 2 weeks, manufacturer says. Indicated for type 2 diabetes management. Expensive and utility remains uncertain.
Medical Mythbusting Commentary for June 18, 2024 Source:World’s first weekly insulin injection coming to Canada in 2 weeks, manufacturer says
-
Glucose monitors may misclassify people as being at risk of diabetes. They are not screening tools and are fraught with misinterpretation and false positives in otherwise healthy people.
Medical Mythbusting Commentary for April 24, 2024 Source:Glucose monitors may misclassify people as being at risk of diabetes
-
GLP-1 receptor agonist lixisenatide may help slow the progression of Parkinson’s symptoms
Medical Mythbusting Commentary for April 10, 2024 Source:Ozempic-like drug may help slow the progression of Parkinson’s symptoms Reference:Trial of Lixisenatide in Early Parkinson’s Disease
-
Small pilot study shows ketogenic diet reduces medication-related metabolic syndrome changes for people being treated for Schizophrenia and Bipolar Disorder
Medical Mythbusting Commentary for April 4, 2024 Source:Pilot study shows ketogenic diet improves severe mental illness Reference:Ketogenic Diet Intervention on Metabolic and Psychiatric Health in Bipolar and Schizophrenia: A Pilot Trial
-
Intermittent fasting is safe, effective for those with Type 2 diabetes for at least 6 months, study suggests. Whether people are able to do this for their lifetime remains to be seen.
Medical Mythbusting Commentary for November 1, 2023 Source:Intermittent fasting is safe, effective for those with Type 2 diabetes, study suggests Reference:Effect of Time-Restricted Eating on Weight Loss in Adults With Type 2 Diabetes
-
Global diabetes cases could soar to 1.3 billion by 2050, new study says.
Medical Mythbusting Commentary for June 26, 2023 Source:Global diabetes cases could soar to 1.3 billion by 2050, new study says Reference:Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021